434 related articles for article (PubMed ID: 32143514)
21. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
23. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
Pupo M; Pisano A; Abonante S; Maggiolini M; Musti AM
Int J Biochem Cell Biol; 2014 Jan; 46():56-67. PubMed ID: 24275097
[TBL] [Abstract][Full Text] [Related]
24. Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors.
Qian H; Xuan J; Liu Y; Shi G
J Immunol Res; 2016; 2016():7128702. PubMed ID: 27314054
[TBL] [Abstract][Full Text] [Related]
25. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
26. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
27. ER-mediated anti-tumor effects of shikonin on breast cancer.
Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
[TBL] [Abstract][Full Text] [Related]
28. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.
Scaling AL; Prossnitz ER; Hathaway HJ
Horm Cancer; 2014 Jun; 5(3):146-160. PubMed ID: 24718936
[TBL] [Abstract][Full Text] [Related]
29. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
30. The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs).
Pupo M; Vivacqua A; Perrotta I; Pisano A; Aquila S; Abonante S; Gasperi-Campani A; Pezzi V; Maggiolini M
Mol Cell Endocrinol; 2013 Aug; 376(1-2):23-32. PubMed ID: 23748028
[TBL] [Abstract][Full Text] [Related]
31. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.
Shan P; Tang B; Xie S; Zhang Z; Fan J; Wei Z; Song C
J Cell Biochem; 2021 Jan; 122(1):3-15. PubMed ID: 32985706
[TBL] [Abstract][Full Text] [Related]
32. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
[TBL] [Abstract][Full Text] [Related]
33. Estrogen regulates Hippo signaling via GPER in breast cancer.
Zhou X; Wang S; Wang Z; Feng X; Liu P; Lv XB; Li F; Yu FX; Sun Y; Yuan H; Zhu H; Xiong Y; Lei QY; Guan KL
J Clin Invest; 2015 May; 125(5):2123-35. PubMed ID: 25893606
[TBL] [Abstract][Full Text] [Related]
34. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
[TBL] [Abstract][Full Text] [Related]
36. The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
Talia M; Cirillo F; Spinelli A; Zicarelli A; Scordamaglia D; Muglia L; De Rosis S; Rigiracciolo DC; Filippelli G; Perrotta ID; Davoli M; De Rosa R; Macirella R; Brunelli E; Miglietta AM; Nardo B; Tosoni D; Pece S; De Francesco EM; Belfiore A; Maggiolini M; Lappano R
J Exp Clin Cancer Res; 2023 Jul; 42(1):164. PubMed ID: 37434266
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Tian S; Zhan N; Li R; Dong W
Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
[TBL] [Abstract][Full Text] [Related]
38. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
[TBL] [Abstract][Full Text] [Related]
39. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]